Sinocelltech Group Limited (688520.SS)

CNY 37.81

(0.11%)

Total Assets Summary of Sinocelltech Group Limited

  • Sinocelltech Group Limited's latest annual total assets in 2023 was 2.71 Billion CNY , down -0.63% from previous year.
  • Sinocelltech Group Limited's latest quarterly total assets in 2024 Q2 was 3.03 Billion CNY , up 7.42% from previous quarter.
  • Sinocelltech Group Limited reported annual total assets of 2.73 Billion CNY in 2022, up 99.24% from previous year.
  • Sinocelltech Group Limited reported annual total assets of 1.37 Billion CNY in 2021, down -17.45% from previous year.
  • Sinocelltech Group Limited reported quarterly total assets of 3.03 Billion CNY for 2024 Q2, up 7.42% from previous quarter.
  • Sinocelltech Group Limited reported quarterly total assets of 2.82 Billion CNY for 2024 Q1, up 4.02% from previous quarter.

Annual Total Assets Chart of Sinocelltech Group Limited (2023 - 2016)

Historical Annual Total Assets of Sinocelltech Group Limited (2023 - 2016)

Year Total Assets Total Assets Growth
2023 2.71 Billion CNY -0.63%
2022 2.73 Billion CNY 99.24%
2021 1.37 Billion CNY -17.45%
2020 1.66 Billion CNY 105.83%
2019 808.19 Million CNY 49.73%
2018 539.75 Million CNY 10.85%
2017 486.93 Million CNY 15.48%
2016 421.67 Million CNY 0.0%

Peer Total Assets Comparison of Sinocelltech Group Limited

Name Total Assets Total Assets Difference
Beijing Tiantan Biological Products Co., Ltd. 14.18 Billion CNY 80.839%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. 4.32 Billion CNY 37.171%
Jinyu Bio-technology Co., Ltd. 6.87 Billion CNY 60.444%
Vcanbio Cell & Gene Engineering Corp., Ltd 5.41 Billion CNY 49.762%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 14.38 Billion CNY 81.101%
Zhejiang Ausun Pharmaceutical Co., Ltd. 2.95 Billion CNY 7.895%
DaShenLin Pharmaceutical Group Co., Ltd. 24.12 Billion CNY 88.731%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 15.71 Billion CNY 82.701%
GuiZhou SanLi Pharmaceutical Co.,Ltd 2.92 Billion CNY 6.914%
Pulike Biological Engineering, Inc. 3.26 Billion CNY 16.666%
Beijing Konruns Pharmaceutical Co.,Ltd. 3.78 Billion CNY 28.097%
Shanghai Hile Bio-Technology Co., Ltd. 1.65 Billion CNY -63.99%
Qingdao Vland Biotech INC. 3.03 Billion CNY 10.399%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 3.17 Billion CNY 14.359%
Aurisco Pharmaceutical Co.,Ltd. 2.57 Billion CNY -5.59%
Zhejiang East Asia Pharmaceutical Co., Ltd. 3.34 Billion CNY 18.688%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 3.06 Billion CNY 11.175%
Mabwell (Shanghai) Bioscience Co., Ltd. 4.45 Billion CNY 38.979%
Beijing Hotgen Biotech Co., Ltd. 3.56 Billion CNY 23.649%
Assure Tech (Hangzhou) Co., Ltd. 5.78 Billion CNY 53.044%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 3.54 Billion CNY 23.362%
Cabio Biotech (Wuhan) Co., Ltd. 1.61 Billion CNY -68.697%
Shanghai Shen Lian Biomedical Corporation 1.59 Billion CNY -70.549%
Nanjing Vazyme Biotech Co., Ltd. 5.74 Billion CNY 52.69%
Shandong Kexing Bioproducts Co,.Ltd 3.03 Billion CNY 10.312%
Shanghai Junshi Biosciences Co., Ltd. 11.34 Billion CNY 76.033%
Shanghai Model Organisms Center, Inc. 1.99 Billion CNY -36.079%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. 2.88 Billion CNY 5.842%
Xiamen Amoytop Biotech Co., Ltd. 2.35 Billion CNY -15.384%
Novogene Co., Ltd. 3.59 Billion CNY 24.368%
Shanghai ZJ Bio-Tech Co., Ltd. 4.07 Billion CNY 33.274%
Chengdu Olymvax Biopharmaceuticals Inc. 1.61 Billion CNY -68.58%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 5.3 Billion CNY 48.755%
Shanghai Haohai Biological Technology Co., Ltd. 7.1 Billion CNY 61.74%
Jiangsu Bioperfectus Technologies Co., Ltd. 3.9 Billion CNY 30.408%
Jiangsu Aidea Pharmaceutical Co., Ltd. 1.74 Billion CNY -55.65%
Chengdu Easton Biopharmaceuticals Co., Ltd. 3.34 Billion CNY 18.771%
Wuhan Keqian Biology Co.,Ltd 4.67 Billion CNY 41.803%
Shanghai Allist Pharmaceuticals Co., Ltd. 4.37 Billion CNY 37.883%
Anhui Huaheng Biotechnology Co., Ltd. 3.97 Billion CNY 31.527%
Youcare Pharmaceutical Group Co., Ltd. 5.91 Billion CNY 54.011%
Jiangsu gdk Biotechnology Co., Ltd. 1.63 Billion CNY -66.618%
Beijing Kawin Technology Share-Holding Co., Ltd. 2.44 Billion CNY -11.042%
Hangzhou Biotest Biotech Co.,Ltd. 2.57 Billion CNY -5.387%